Alharbi, N.S.; Nader, M.A.; Serrya, M.S.; Abdelmageed, M.E.
Ambrisentan Exhibits Hepatoprotective Effects Against NASH-Associated Hepatic Injury in Dexamethasone-Treated Rats Through Regulation of Inflammation, Ferroptosis and Autophagy. Pharmaceuticals 2026, 19, 798.
https://doi.org/10.3390/ph19050798
AMA Style
Alharbi NS, Nader MA, Serrya MS, Abdelmageed ME.
Ambrisentan Exhibits Hepatoprotective Effects Against NASH-Associated Hepatic Injury in Dexamethasone-Treated Rats Through Regulation of Inflammation, Ferroptosis and Autophagy. Pharmaceuticals. 2026; 19(5):798.
https://doi.org/10.3390/ph19050798
Chicago/Turabian Style
Alharbi, Naif S., Manar A. Nader, Marwa S. Serrya, and Marwa E. Abdelmageed.
2026. "Ambrisentan Exhibits Hepatoprotective Effects Against NASH-Associated Hepatic Injury in Dexamethasone-Treated Rats Through Regulation of Inflammation, Ferroptosis and Autophagy" Pharmaceuticals 19, no. 5: 798.
https://doi.org/10.3390/ph19050798
APA Style
Alharbi, N. S., Nader, M. A., Serrya, M. S., & Abdelmageed, M. E.
(2026). Ambrisentan Exhibits Hepatoprotective Effects Against NASH-Associated Hepatic Injury in Dexamethasone-Treated Rats Through Regulation of Inflammation, Ferroptosis and Autophagy. Pharmaceuticals, 19(5), 798.
https://doi.org/10.3390/ph19050798